Short-term administration of ACTH improves plasma lipid profile and renal function in kidney transplant patients

被引:8
作者
He, X.
Xue, P.
Xu, X.
Luo, G.
Zhou, G.
Nilsson-Ehle, P.
Xu, N. [1 ]
机构
[1] Lund Univ, Sect Clin Chem & Pharmacol, Inst Lab Med, S-22185 Lund, Sweden
[2] Suzhou Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China
关键词
D O I
10.1016/j.transproceed.2006.02.090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study investigated effects of short-term administration of adrenocorticotrophic hormone (ACTH) on blood lipid profile and renal function in kidney transplant patients. Six patients who had kidney transplantations 2 to 10 years earlier received ACTH intramuscularly (1 mg/d) for 4 days. We analyzed serum levels of lipids, lipoproteins, apolipoproteins, blood creatinine, and other parameters. Short-term ACTH treatment significantly decreased serum apolipoprotein B and apolipoprotein AI, whereas it significantly increased plasma high-density lipoproteins (HDL). Interestingly, creatinine level moderately decreased and creatinine clearances moderately increased among five of six patients. Hepatic function and serum concentration of cyclosporine did not change. There were no serious side effects during ACTH treatment. It was concluded that ACTH treatment had beneficial effects on serum lipoprotein profile, potentially improving renal function in kidney transplant patients. Further observations are needed to confirm these effects.
引用
收藏
页码:1371 / 1374
页数:4
相关论文
共 27 条
[1]   Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
CLINICAL TRANSPLANTATION, 2004, 18 (05) :596-604
[2]   Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation [J].
Aguilar-Salinas, CA ;
Díaz-Polanco, A ;
Quintana, E ;
Macias, N ;
Arellano, A ;
Ramírez, E ;
Ordóñez, ML ;
Velásquez-Alva, C ;
Pérez, FJG ;
Alberú, J ;
Correa-Rotter, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01) :169-177
[3]   Cardiovascular risk factors and diseases after renal transplantation [J].
Aker S. ;
Ivens K. ;
Grabensee B. ;
Heering P. .
International Urology and Nephrology, 1998, 30 (6) :777-788
[4]  
Andany MA, 2001, J NEPHROL, V14, pS81
[5]   Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: Relation to apolipoprotein(a) size polymorphism [J].
Arnadottir, M ;
Berg, AL ;
Kronenberg, F ;
Lingenhel, A ;
Hugosson, T ;
Hegbrant, J ;
Nilsson-Ehle, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (03) :342-346
[6]   Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patients [J].
Arnadottir, M ;
Berg, AL ;
Dallongeville, J ;
Fruchart, JC ;
NilssonEhle, P .
KIDNEY INTERNATIONAL, 1997, 52 (06) :1651-1655
[7]  
Arnadottir M, 2001, SCAND J CLIN LAB INV, V61, P301
[8]   Pharmacologic immunosuppression [J].
Barshes, NR ;
Goodpastor, SE ;
Goss, JA .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :411-420
[9]   Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy [J].
Berg, AL ;
Nilsson-Ehle, P ;
Arnadottir, M .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1534-1543
[10]   ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease [J].
Berg, AL ;
NilssonEhle, P .
KIDNEY INTERNATIONAL, 1996, 50 (02) :538-542